Mental Health
Books 2016
Welcome to the Mental Health books catalogue 2016. Here you will find new and forthcoming titles, representing the highest level of clinical practice from renowned authors. The continuum leading from psychiatry, through clinical psychology, neuropsychology, neurology, and then through neuropsychiatry back to psychiatry again, provides a highly cohesive focus to the Cambridge list in mental health and the clinical brain sciences. We have broad coverage across all the major specialties. There is a particular strength in psychopharmacology. The major disorder-groups are well covered and there are significant clusters of titles in areas like the addictions, eating disorders, sleep disorders and trauma. The list is further supported by a strong selection of related journals. Our publications are available in a variety of formats, including ebooks and print, as well as online collections for institutional purchase via our publishing service University Publishing Online, which incorporates the Cambridge Books Online platform. To see more book listings, product information, extracts and reviews, you can find us online at www.cambridge.org/medicine You can also keep up to date with the latest news and author views by visiting our Cambridge Medicine blog at www.cambridgemedicine.wordpress.com We are always keen to expand our Mental Health publishing program and would be very pleased to talk to you about any new publishing possibilities – books, journals or digital products - in the field. You can find a list of useful contacts by going to www.cambridge.org/meditors We hope that you enjoy reading about our latest publications.
Contents Follow us on Twitter @cambUP_medicine
Order online now at www.cambridge.org/mentalhealth General enquiries: +44 (0)1223 326050 When purchasing, please quote the product ISBNs. For information about our privacy and data protection policy, please visit www.cambridge.org/privacy or email mlist@cambridge.org
Key Highlights
3
Stephen M. Stahl
8
Mental Health, Psychiatry and Clinical Psychology
11
Key Highlights Clinical Psychology for Trainees Foundations of Science-Informed Practice Second edition Andrew C. Page University of Western Australia, Perth
and Werner G. K. Stritzke
School Mental Health Global Challenges and Opportunities Edited by Stan Kutcher Dalhousie University and the IWK Health Centre, Nova Scotia
Yifeng Wei Dalhousie University and the IWK Health Centre, Nova Scotia
University of Western Australia, Perth
and Mark D. Weist
Fully updated for DSM-5, with three new chapters, this revised edition covers practical clinical skills with a focus on the scientist-practitioner model. It provides clinical psychology trainees with a practical template for making use of evidence-based science in interviewing, diagnosis, assessment, treatment and case management.
University of South Carolina
Review of previous edition: ‘The authors argue convincingly that clinical psychologists working under modern cost-cutting and risk-averse conditions must demonstrate the efficiency and safety of their work scientifically if they are to survive in the workplace. Those considering, or just embarking on clinical training would do well to read this book, to develop a sense of ‘science’ as an ally and not a foe.’ Caroline Plumb, Journal of Psychosomatic Research Contents: Preface; 1. A science-informed model of clinical psychology practice; 2. Relating with clients; 3. Assessing clients; 4. Monitoring client progress; 5. Linking assessment to treatment: case formulation; 6. Treating clients; 7. Brief interventions; 8. Group treatment; 9. Program evaluation; 10. Case management; 11. Supervision; 12. Managing ruptures in therapeutic alliance; 13. Respecting the humanity of clients: cross-cultural and ethical aspects of practice; 14. Working in rural and remote settings; 15. Psychologists as health care providers; Index. 2014 234 x 156 mm 292pp 71 b/w illus. 7 tables 978-1-107-61398-0 Paperback £45.00 / US$70.00 For all formats available, see
www.cambridge.org/9781107613980
3
This book provides vivid examples of school mental health innovations from eighteen countries, addressing mental health promotion, prevention and interventions. These initiatives and innovations enable readers from different regions and disciplines to apply strategies to help students achieve and maintain mental health, enhance their learning outcomes and access services, worldwide.
potential; 15. The current state of school mental health approaches and initiatives in Mexico and Chile; 16. Flourishing schools in Aotearoa, New Zealand: the wellbeing in schools model; 17. Universal schooling and mental health: towards school mental health in Northern Ghana; 18. A Singapore model – REACH; 19. Improving mental health via schools: a perspective from Istanbul, Turkey; 20. School and community mental health promotion strategies for youth in Ukraine; 21. Innovative contemplative/mindfulness based approaches to mental health in schools; 22. The life course model for providing empirically supported school-based services for adolescents; 23. Interconnecting school mental health and school-wide positive behavior support; 24. Global school mental health: considerations and future directions; Index. 2015 234 x 156 mm 333pp 15 b/w illus. 16 tables 978-1-107-05390-8 Hardback £95.00 / US$150.00 For all formats available, see
www.cambridge.org/9781107053908
‘This book provides important insights into how SMH focusing specifically on adolescents is engaged and practiced in international contexts and is a worthy contribution to the research and dialogue on the emerging global agenda for SMH.’ Susan Catapano and Candace Thompson, PsycCRITIQUES
Contents: List of contributors; 1. The global advancement of school mental health for adolescents; 2. Developing and sustaining mental health and wellbeing in Australian schools; 3. The ‘Cool Mind’ program (‘Programa Cuca Legal’): mental health literacy for middle and high school teachers of the public system in Brazil; 4. A collaborative and sustainable approach to address mental health promotion and early identification in schools in the Canadian Province of Nova Scotia and beyond; 5. The future of teaching mental health literacy in schools; 6. School centred mental health: creating school connectedness that fosters the mental wellness of its community’s children, youth and families; 7. Components of mental health care in schools in China: an overview; 8. Mental health education for children and adolescents in China; 9. School mental health programs in India: current status and future directions; 10. School mental health: a perspective from Iraq; 11. Supporting a whole school approach to mental health promotion and wellbeing in post-primary schools in Ireland; 12. School mental health in Israel: background, services and challenges; 13. Development of a mental health literacy program for secondary school students in Japan; 14. A peer mental health educator model for African schools: untapped
eBooks available at www.cambridge.org/ebookstore
4
Key Highlights
Parental Psychiatric Disorder Distressed Parents and their Families Third edition Edited by Andrea Reupert Monash University, Victoria
Darryl Maybery Monash University, Victoria
Joanne Nicholson Dartmouth Psychiatric Research Center
Michael Göpfert University of Liverpool
and Mary V. Seeman University of Toronto
Parental Psychiatric Disorder presents an innovative approach to thinking about and working with families where a parent has mental illness. This is a must-read for researchers, students and clinicians. It addresses issues from a multidisciplinary, international perspective that is innovative, whole family focused, developmental, culturally informed and recovery oriented. Contents: Preface; Part I. Fundamental Issues: 1. Towards the development of a conceptual framework; 2. What we want from mental health professionals: ‘telling it like it is’; 3. Parental mental illness: estimating prevalence to inform policy and practice; 4. The effect of parents’ psychiatric disorder on children’s attachment: theory and cases; 5. Assessing the economic costs of parental mental illness; 6. Stigma and families where a parent has a mental illness; Part II. Comprehensive Assessment: 7. Assessment and formulation of parenting; 8. Assessment of parents for the court; 9. Thinking about children of parents with mental illnesses as a form of intergenerational practice; 10. Parental diagnosis and children’s outcomes; Part III. Specific Disorders: The Impact on Children, Parenting and Family Relationships: 11. Schizophrenia and motherhood; 12. The impact of parental depression on children; 13. Parents with anxiety disorders; 14. Children of alcohol and other drug abusing parents; 15. Mothers with eating disorders and their children; 16. Parenting and borderline personality disorder; 17. Working with parental personality disorder: key issues for mental health professionals and services; 18. Parenting, immigration status, and mental health; Part IV. Child, Parent and Family Interventions: 19. Helping children understand their parent’s mental illness; 20. Psychopharmacology and motherhood; 21. Enhancing depressed mothers’ sensitivity; 22. Working with parents who have a psychiatric disorder; 23. Grandparents as primary caregivers; 24. Interventions for families when a parent has depression;
25. Creating positive parenting experiences: family options; Part V. Building Workforce, Organisational and Community Capacity: 26. Parental psychiatric disorder: translating the family model into practice change; 27. E-learning professional development resources for families where a parent has a mental illness; 28. How can we make the psychiatric workforce more family focused?; 29. A personal recovery model for parents with mental health problems; 30. Helping parents with mental illness: the value of professional partnerships fighting de facto bias in the American courts; 31. Preventing unnecessary loss of child custody; 32. Shifting the intervention paradigm from individuals to families living with parental mental illness; 33. The policy context and change for families living with parental mental illness; 34. Are we there yet? Developing a conceptual framework for understanding families where a parent has a mental illness; Index. 2015 234 x 156 mm 389pp 20 b/w illus. 5 tables 978-1-107-07068-4 Hardback £69.99 / US$115.00 For all formats available, see
www.cambridge.org/9781107070684
Cognitive Impairment in Major Depressive Disorder Clinical Relevance, Biological Substrates, and Treatment Opportunities Edited by Roger S. McIntyre University of Toronto
Edited in association with Danielle S. Cha University of Toronto
Major depressive disorder is a common, often severe, disorder identified as a leading cause of disability globally. The associated economic and human costs are a direct consequence of disturbances in cognitive function. This is the first book to assemble research, clinical and public policy perspectives on cognitive dysfunction in MDD. Contents: Preface; Part I. Clinical Relevance of Cognitive Dysfunction in Major Depressive Disorder: 1. Does cognitive dysfunction predate the onset of incident depression?; 2. Understanding the importance of cognitive dysfunction and cognitive change in major depressive disorder; 3. Cognition in MDD implications for primary care; 4. Neurocognition in pediatric depression; 5. Neuroanatomy of cognition in major depressive disorder (hot and cold); 6. Hot and cold cognition in major depressive disorder; 7. Social cognition and emotional processing
in major depressive disorder; 8. The role of social cognition in major depressive disorder; 9. Are cognitive deficits in major depressive disorder progressive?; 10. Implications of cognitive impairments on functional outcomes in major depressive disorder; Part II. Underlying Biological Substrates Associated with Cognitive Dysfunction in Major Depressive Disorder: 11. Cognition and biomarkers in major depressive disorder (MDD): endophenotype or epiphenomenon?; 12. Inflammation and cognition in major depressive disorder; 13. HPA axis and cognitive dysfunction in mood disorders; 14. White matter neurobiology and cognitive dysfunction in major depressive disorder; 15. Insulin resistance and implications for hippocampal volume/function and the default mode network; Part III. Evaluating Cognitive Dysfunction in Major Depressive Disorder: 16. Measuring the mind: detecting cognitive deficits and measuring cognitive change in patients with depression; 17. Subjective measures of cognitive dysfunction in major depressive disorder; Part IV. Treatment Opportunities for Ameliorating Cognitive Dysfunction in Major Depressive Disorder: 18. Neuroscience of functional outcomes and treatment targets in major depressive disorder; 19. Treatment of cognitive dysfunction in adults with major depressive disorder; 20. A novel treatment targeting cognitive dysfunction in mood disorders; 21. Cognitive remediation for major depressive disorder; 22. Exercise and cognition; Index. 2016 234 x 156 mm 370pp 26 b/w illus. 7 colour illus. 19 tables 978-1-107-07458-3 Hardback £74.99 / US$120.00 For all formats available, see
www.cambridge.org/9781107074583
Key Highlights
Psychiatric and Behavioral Disorders in Intellectual and Developmental Disabilities Third edition Edited by Colin Hemmings Albion Place Medical Centre
and Nick Bouras Institute of Psychiatry, London
This fully revised new edition reviews the latest evidence base on the psychiatric disorders and behavioral problems of those with coexisting intellectual and developmental disorders. It covers the essential facts and concepts, and highlights the principles for clinical practice in assessment, management and service provision, offering hands-on practical advice. Contents: List of contributors; Preface; Part I. Foundations: 1. Historical and international perspectives of services; 2. Classification and diagnosis; 3. The epidemiology of psychiatric disorders in adults with intellectual disabilities; 4. Assessment instruments and rating scales; Part II. Mental Disorders: 5. Dementias; 6. Schizophrenia spectrum disorders; 7. Mood disorders; 8. Anxiety disorders; 9. Stress, traumatic and bereavement reactions; 10. Personality disorders; 11. Mental illness with intellectual disabilities and autism spectrum disorders; 12. Attention-deficit hyperactivity disorder (ADHD); Part III. Interventions: 13. Psychopharmacology; 14. Psychodynamic psychotherapy; 15. Cognitive behavioural therapy; 16. Behavioural approaches; Part IV. Special Topics: 17. Psychopathology of children with intellectual disabilities (ID); 18. Behavioural phenotypes/genetic syndromes; 19. Offending behaviour; 20. Problem behaviours and the interface with psychiatric disorders; 21. The interface between medical and psychiatric disorders; 22. Epilepsy; Part V. Services: 23. Specialized and mainstream mental health services; 24. Service users’ and carers’ experiences of mental health services; 25. Carer and family perspectives; Part VI. Reflections: 26. Reflections; Index. 2016 234 x 156 mm 310pp 2 b/w illus. 1 table 978-1-107-64594-3 Paperback £59.99 / US$94.99 For all formats available, see
www.cambridge.org/9781107645943
Comprehensive Women’s Mental Health
Physical Exercise Interventions for Mental Health
Edited by David J. Castle
Edited by Linda C. W. Lam
University of Melbourne
The Chinese University of Hong Kong
and Kathryn M. Abel
and Michelle Riba
University of Manchester
University of Michigan, Ann Arbor
A comprehensive, evidence-based review covering the broader social, genetic and developmental context of women’s mental health, with detailed clinical chapters covering disorders such as depression, bipolar disorder, schizophrenia and dementia. A detailed but practical resource for mental health practitioners, general physicians, nurses, social workers and psychologists.
Exercise is well known to be beneficial to physical health; however, increasing research indicates that physical exercise is also beneficial to brain health and may alleviate symptoms of mental disorders. This book describes and explores the theory and practice of exercise intervention for different mental disorders across the life span.
Contents: Preface; Part I. The Social, Genetic and Developmental Context: 1. Surviving their lives: women’s mental health in context; 2. Ethnic and cultural effects on mental healthcare for women; 3. Women as caregivers; 4. Maternal caregiving, oxytocin and mental illness; 5. Genetic, epigenetic and gene-environment interactions: impact on the pathogenesis of mental illnesses in women; 6. Developmental disorders in girls: focus on autism spectrum disorders; 7. Pubertal development and the emergence of the gender gap in affective disorders: a developmental and evolutionary synthesis; Part II. Hormonal and Reproductive Effects: 8. The effects of hormones on the female brain across the lifespan; 9. Sexual, reproductive and antenatal care of women with mental illness; 10. Mood, anxiety and obsessive compulsive disorders in pregnancy and the postpartum period: phenomenology and epidemiology; 11. Pharmacological treatment of mental health problems in pregnancy and lactation; Part III. Violence, Self-Harm and Substance Misuse in Women: 12. Borderline personality disorder: sex differences; 13. Women offenders and mental health; 14. Domestic violence and women’s mental health; 15. Women and addiction; Part IV. Depression, Anxiety and Related Disorders: 16. Body image disorders in women; 17. Post-traumatic stress disorder in women; 18. Anxiety disorders in women; 19. Depression: special issues in women; 20. Anxiety and depression in women in old age; Part V. Psychotic Disorders in Women: 21. Bipolar disorders: special issues for women; 22. Women and schizophrenia; 23. Treating women with schizophrenia; 24. Psychotic disorders in women in later life; 25. Dementia in women; Index.
5
Contents: 1. Recent developments of physical activity interventions as an adjuvant therapy in mental disorders; 2. Exercise interventions for youth with psychiatric disorders; 3. Exercise for the treatment of depression; 4. Activity intervention for first episode psychosis; 5. Aerobic exercise for people with schizophrenic psychosis; 6. Physical exercise to calm your ‘nerves’; 7. The Treatment with Exercise Augmentation for Depression (TREAD) study; 8. Physical activity interventions for minor and major neurocognitive disorders; 9. Yoga-based interventions for the management of psychiatric disorders; 10. Physical exercise for brain health in later life: how does it work?; 11. Depression and cardiovascular risk: exercise as a treatment; Index. 2016 234 x 156 mm 196pp 4 b/w illus. 19 tables 978-1-107-09709-4 Hardback £44.99 / US$74.99 For all formats available, see
www.cambridge.org/9781107097094
2016 246 x 189 mm 369pp 6 b/w illus. 16 tables 978-1-107-62269-2 Paperback £49.99 / US$79.99 For all formats available, see
www.cambridge.org/9781107622692
For regular email alerts visit www.cambridge.org/alerts
6
Key Highlights
The Self in Understanding and Treating Psychological Disorders Edited by Michael Kyrios Australian National University, Canberra
Richard Moulding Deakin University, Victoria
Guy Doron Baruch Ivcher School of Psychology, Interdisciplinary Center (IDC), Herzliya, Israel
Sunil S. Bhar Swinburne University of Technology, Victoria
Maja Nedeljkovic Swinburne University of Technology, Victoria
and Mario Mikulincer Baruch Ivcher School of Psychology, Interdisciplinary Center (IDC), Herzliya, Israel
Foreword by Aaron T. Beck
This must-have reference suggests a new way forward in our understanding of how the ‘self’ and related constructs, such as early schemas and attachment, impact on psychopathology, psychotherapy processes and treatment outcomes across psychological and cognitive conditions, such as depression, anxiety, schizophrenia, self-regulation disorders, and autism, offering alternative intervention techniques. ‘The Self in Understanding and Treating Psychological Disorders is a treasure trove of information for both researchers and clinical practitioners. It offers plenty of useful insights as well as fascinating findings from research. The different chapters complement each other effectively. The human self is an important foundation for any quest to understand human nature and human behavior, and these chapters vividly and clearly describe what happens to the self in the context of psychopathology. The book is an informative and thought-provoking read, useful for anyone wanting an introduction or update to this vast and fast-moving field.’ Roy F. Baumeister, Florida State University, and author of Willpower: Rediscovering the Greatest Human Strength
Contents: Foreword; List of contributors; Section 1. Introduction and Concepts: 1. The self in psychological disorders: an introduction; 2. The self-concept: theory and research; 3. Adult attachment and self-related processes; Section 2. The Self in Treatment Frameworks: 4. Working with the future: a psychodynamic-integrative approach to treatment; 5. Finding the self in a cognitive behavioural perspective; 6. The self in acceptance and commitment therapy; 7. The
self in schema therapy; Section 3. The Self in Specific Psychological Disorders: 8. The self in depression; 9. The self in bipolar disorder; 10. The self in social anxiety; 11. The self in post-traumatic stress disorder; 12. Self processes in obsessive compulsive disorder; 13. The self in the obsessive compulsiverelated disorders: hoarding disorder, body dysmorphic disorder, and trichotillomania; 14. Self-regulation in disordered gambling: a comparison with alcohol and substance use disorders; 15. The self in autism; 16. Basic self disturbance in the schizophrenia spectrum: a review and future directions; 17. Painful incoherence: the self in borderline personality disorder; 18. The self in obsessive compulsive personality disorder; 19. The self in chronic fatigue syndrome; 20. The self in eating disorders; 21. The self in dementia; 22. The self in gender dysphoria: a developmental perspective; Section 4. Conclusions and Future Directions: 23. Future directions in examining the self in psychological disorders; Index. 2016 246 x 189 mm 255pp 3 b/w illus. 11 tables 978-1-107-07914-4 Hardback £49.99 / US$79.99 For all formats available, see
www.cambridge.org/9781107079144
Moral Jeopardy Risks of Accepting Money from the Alcohol, Tobacco and Gambling Industries Peter J. Adams University of Auckland
Tobacco, alcohol and gambling corporations have been highly effective in stalling, diverting and blocking public health measures. This book provides an original and engaging exposé of the ethical issues faced by people and organizations when they accept industry money in ways that facilitate corporate influence with policy makers. Contents: Preface; Acknowledgements; Part I. Addictive Consumptions: 1. Why it matters; 2. Addiction surplus; 3. Profit consumption; Part II. Concepts: 4. Moral jeopardy; 5. Silencing effects; 6. Psychology of moral jeopardy; 7. Climate of permissibility; Part III. Role Dilemmas: 8. Industry opportunities; 9. Health provider dilemmas; 10. Government maneuverings; 11. Community dilemmas; 12. Researcher dilemmas; Part IV. Prevention Strategies: 13. A prevention framework; 14. Moral jeopardy self-assessment; 15. Hearts and minds; 16. Positional statements; 17. Consuming futures; 18. Conclusion; Permissions; Index. International Research Monographs in the Addictions
2016 234 x 156 mm 304pp 19 b/w illus. 21 tables 978-1-107-09120-7 Hardback £79.99 / US$130.00 Publication March 2016 For all formats available, see
www.cambridge.org/9781107091207
Key Highlights
Bipolar Disorders Basic Mechanisms and Therapeutic Implications Third edition Edited by Jair C. Soares University of Texas Health Science Center, Houston
and Allan Young King’s College London
This new edition covers groundbreaking advances in the fields of genetics, neuropsychopharmacology, psychosocial factors, and many other important areas, emphasizing the therapeutic implications and potential of this new understanding. It will be essential reading for those interested in the neurobiology of mental illness and in mental health more generally. Contents: List of contributors; Preface; 1. The classification of bipolar disorders: implications for clinical research; 2. Prospects for the development of animal models for the study of bipolar disorder; 3. Abnormalities in catecholamines and the pathophysiology of bipolar disorder; 4. Serotonergic dysfunction in bipolar disorder; 5. Involvement of GABAergic/glutamatergic pathways in mood disorders; 6. Oxidative stress and neuronal resilience: implications for the pathophysiology of bipolar disorders; 7. Post-mortem studies in bipolar disorder; 8. The neuroendocrinology of stress in the pathophysiology of bipolar disorders; 9. Brain imaging abnormalities in bipolar disorder; 10. Sleep and circadian rhythms in bipolar disorders; 11. Infectious agents: role in causation of bipolar disorders?; 12. EEGs and ERPs in bipolar disorders; 13. Genetic factors in the etiology of bipolar disorder; 14. Neurocognitive findings in bipolar disorder; 15. Psychotherapeutic interventions in bipolar disorder; 16. The kindling/ sensitization model and the pathophysiology of bipolar disorder; 17. Biological factors in bipolar disorder in childhood and adolescence; 18. Biological factors in bipolar disorder in late life; 19. Perspectives for new pharmacological interventions; 20. Physical health and metabolic dysfunction in bipolar disorder; 21. Immune dysregulation in bipolar disorder; Index. 2016 246 x 189 mm 320pp 7 b/w illus. 9 colour illus. 23 tables 978-1-107-06271-9 Hardback £84.99 / US$135.00
Adult Personality Growth in Psychotherapy Mardi J. Horowitz University of California, San Francisco
This book will expand your therapeutic repertoire. Once crises have been resolved, the clinician and patient explore what can change in order to increase the patient’s capacities for balance, harmony and satisfaction. The outcome is the achievement of a wider range of safe emotional expression and mastery of previous traumas and losses. Contents: Preface; Acknowledgements; 1. Advancing personality growth in psychotherapy; Part I. Self-Organization: 2. Self-organization; 3. Identity functioning and self-states; 4. Possibilities for change in self-narratives; Part II. Relationships: 5. Changing relationship patterns; 6. Advancing relationship capacities; 7. Improving maladaptive patterns in sexual relationships; Part III. Control and Emotional Regulation: 8. Control of unconscious emotional potentials; 9. Defensive styles; 10. Emotional avoidance maneuvers; References; Index. 2016 234 x 156 mm 160pp 6 b/w illus. 12 tables 978-1-107-53296-0 Paperback c. £27.99 / c. US$44.99 Publication April 2016 For all formats available, see
www.cambridge.org/9781107532960
7
Edwards’ Treatment of Drinking Problems A Guide for the Helping Professions Sixth edition Keith Humphreys Stanford University School of Medicine, California
and Anne Lingford-Hughes Imperial College London
Presenting state-of-the-art, accessible reviews of the expanding science of alcohol treatment, integrated with practical guides to the management of a wide range of clinical situations, this new edition is compassionate toward patients, optimistic about treatment, and candid about the clinical and professional challenges embedded in the treatment endeavour. Contents: A note on the sixth edition; Introduction; Part I. Background to Understanding: 1. Definitions of drinking problems; 2. Alcohol as a drug; 3. Causes of drinking problems; 4. Social complications of drinking problems; 5. Physical complications of excessive drinking; 6. Drinking problems and psychiatric disorders; 7. Alcohol and other drug problems; Part II. Treatment: Context and Content: 8. Introduction, settings and roles; 9. Case-finding and intervention in non-specialty settings; 10. Assessment of patients with drinking problems; 11. Withdrawal states and their clinical management; 12. The therapeutic relationship; 13. Specialist treatment of drinking problems; 14. Alcoholics Anonymous and other mutual-help organizations; 15. Religion, spirituality and values in the treatment of drinking problems; 16. Pursuing treatment outcomes other than abstinence; 17. Managing setbacks and challenges in the treatment of drinking problems; Epilogue; Index. 2016 234 x 156 mm 234pp 14 b/w illus. 27 tables 978-1-107-51952-7 Paperback £49.99 / US$79.99 Publication April 2016 For all formats available, see
www.cambridge.org/9781107519527
Publication April 2016 For all formats available, see
www.cambridge.org/9781107062719
Visit our website at www.cambridge.org/academic
8
Stephen M. Stahl Highlight
Prescriber’s Guide Stahl’s Essential Psychopharmacology Fifth edition Stephen M. Stahl University of California, San Diego
Assisted by Meghan M. Grady Illustrated by Nancy Murtner
With coverage of 16 brand-new drugs – including six fresh-to-market critical new compounds – and incorporating the latest information on new indications, new formulations, new recommendations and new safety data, the fifth edition of this indispensable guide provides the essential practical support required by anyone prescribing in the field of mental health. ‘[Dr Stahl] crams a remarkable amount of concisely expressed, up-to-date information into his book … The combination of up-to-date information with such a reader friendly presentation is what makes Dr Stahl’s work so welcome.’ Journal of Clinical Psychiatry Contents: 1. Acamprosate; 2. Agomelatine; 3. Alprazolam; 4. Amisulpride; 5. Amitriptyline; 6. Amoxapine; 7. Amphetamine (d); 8. Amphetamine (d,l); 9. Aripiprazole; 10. Armadafinil; 11. Asenapine; 12. Atomoxetine; 13. Benztropine; 14. Blonanserin; 15. Buprenorphine; 16. Bupropion; 17. Buspirone; 18. Caprylidene; 19. Carbamazepine; 20. Chlordiazepoxide; 21. Chlorpromazine; 22. Citalopram; 23. Clomipramine; 24. Clonazepam; 25. Clonidine; 26. Clorazepate; 27. Clozapine; 28. Cyamemazine; 29. Desipramine; 30. Desvenlafaxine; 31. Dextromethorphan; 32. Diazepam; 33. Diphenhydramine; 34. Disulfiram; 35. Donepezil; 36. Dothiepin; 37. Doxepin; 38. Duloxetine; 39. Escitalopram; 40. Estazolam; 41. Eszopiclone; 42. Flumazenil; 43. Flunitrazepam; 44. Fluoxetine; 45. Fluphenthixol; 46. Fluphenazine; 47. Flurazepam; 48. Fluvoxamine; 49. Gabapentin; 50. Galantamine; 51. Guanfacine; 52. Haloperidol; 53. Hydroxyzine; 54. I-methylfolate; 55. Iloperidone; 56. Imipramine; 57. Isocarboxazid; 58. Ketamine; 59. Lamotrigine; 60. Levetiracetam; 61. Levomilnacipran; 62. Lisdexamfetamine; 63. Lithium; 64. Lorcaserin; 65. Lofepramine;
66. Loflazeptate; 67. Lorazepam; 68. Loxapine; 69. Lurasidone; 70. Mainserin; 71. Maprotiline; 72. Memantine; 73. Mesoridazine; 74. Methylphenidate (d); 75. Midazolam; 76. Milnacipran; 77. Mirtazapine; 78. Moclobemide; 79. Modafinil; 80. Molindone; 81. Nalmefene; 82. Naltrexone; 83. Nefazodone; 84. Nortriptyline; 85. Olanzapine; 86. Oxazepam; 87. Oxcarbazepine; 88. Paliperidone; 89. Paroxetine; 90. Perospirone; 91. Perphenazine; 92. Phenelzine; 93. Phenterminetopiramate; 94. Pimozide; 95. Pipothiazine; 96. Prazosin; 97. Pregabalin; 98. Propranolol; 99. Protriptyline; 100. Quazepam; 101. Quetiapine; 102. Ramelteon; 103. Reboxetine; 104. Risperidone; 105. Rivastigmine; 106. Selegiline; 107. Sertindole; 108. Sertraline; 109. Sodium Oxybate; 110. Sulpiride; 111. Temazepam; 112. Thioridazine; 113. Thiothixene; 114. Tiagabine; 115. Tianeptine; 116. Trihexyphenidyl; 117. Triiodothyronine; 118. Topiramate; 119. Tranylcypromide; 120. Trazodone; 121. Triazolam; 122. Trifluoperazine; 123. Trimipramine; 124. Valproate; 125. Varenicline; 126. Venlafaxine; 127. Vortioxetine; 128. Zalepron; 129. Ziprasidone; 130. Zolpidem; 131. Zonisamide; 132. Zopiclone; 133. Zotepine; 134. Zuclopenthixol. 2014 228 x 138 mm 824pp 2 b/w illus. 978-1-107-67502-5 Paperback £64.99 / US$105.00 For all formats available, see
www.cambridge.org/9781107675025
Stahl’s Illustrated Violence Neural Circuits, Genetics and Treatment Stephen M. Stahl University of California, San Diego
Assisted by Debbi Ann Morrissette Neuroscience Education Institute
This pocket-sized volume in the Stahl’s Illustrated series combines theoretical information from Stahl’s Essential Psychopharmacology with practical data from The Prescriber’s Guide. This highly-illustrated guide presents the underlying neurobiology, genetic predisposition and management of aggressive behaviours in patients with psychiatric disorders. Contents: Preface; CME information; Objectives; Introduction; 1. Which individuals will become violent or aggressive?; 2. Neurobiology and genetics of violence and aggression; 3. Treatment of violence and aggression; Summary; References; Index; CME: posttest and certificate. Stahl’s Illustrated
2014 210 x 146 mm 120pp 978-1-107-44160-6 Paperback £31.99 / US$49.99 For all formats available, see
www.cambridge.org/9781107441606
Stephen M. Stahl
Prescriber’s Guide: Antidepressants Stahl’s Essential Psychopharmacology Fifth edition Stephen M. Stahl University of California, San Diego
Assisted by Meghan M. Grady Illustrated by Nancy Murtner
This spin-off from Stephen Stahl’s new, completely revised, and fully updated fifth edition of the Prescriber’s Guide covers the most important drugs in use today for treating depression. Contents: Introduction; List of icons; Agomelatine; Amisulpride; Amitriptyline; Amoxapine; Amphetamine (d); Amphetamine (d,l); Armodafinil; Aripiprazole; Asenapine; Atomoxetine; Bupropion; Buspirone; Citalopram; Clomipramine; Cyamemazine; Desipramine; Desvenlafaxine; Dothiepin; Doxepin; Duloxetine; Escitalopram; Fluoxetine; Flupenthixol; Fluvoxamine; Iloperidone; Imipramine; Isocarboxazid; Ketamine; Lamotrigine; Lisdexamfetamine; Lithium; Lofepramine; Lurasidone, Maprotiline; Methylphenidate (d); Methylphenidate (d,l); Methylfolate (l); Mianserin; Milnacipran; Mirtazapine; Moclobemide; Modafinil; Nefazodone; Nortriptyline; Olanzapine; Paroxetine; Phenelzine; Protriptyline; Quetiapine; Reboxetine; Selegiline; Sertindole; Sertraline; Sulpiride; Tianeptine; Tranylcypromine; Trazodone; Triiodothyronine; Trimipramine; Venlafaxine; Vilazodone; Vortioxetine; Index by drug name; Index of use. 2014 228 x 140 mm 427pp 978-1-107-47617-2 Paperback £44.99 / US$69.99 For all formats available, see
www.cambridge.org/9781107476172
The Stahl Neuropsychopharmacology
Masterclass: Mood Disorders
Stahl’s SelfAssessment Examination in Psychiatry
Part 1: Mood Disorders The Neuroscience Education Institute
Multiple Choice Questions for Clinicians
An online educational program of courses focusing on core areas of psychiatric research and practice. The content of each course consists of interactive readings, short lectures, animations and case studies. This course on mood disorders is certified for 14.25 CME credits. An ideal resource for busy mental health professionals.
Second edition Stephen M. Stahl
Contents: Pre-course self assessment; Description of mood disorders; The bipolar spectrum; Distinguishing unipolar depression from bipolar depression; Are mood disorders progressive; Neurotransmitters and circuits in mood disorders; Stress and depression; Symptoms and circuits in depression; Symptoms and circuits in mania; Neuroimaging in mood disorders; Post-course self assessment. 2015 978-1-107-59322-0 Online Resource £65.00 / US$99.00 For all formats available, see
www.cambridge.org/9781107593220
The Stahl Neuropsychopharmacology
Masterclass: Antidepressants
Part 2: Antidepressants The Neuroscience Education Institute
An online educational program of courses focusing on core areas of psychiatric research and practice. The content of each course consists of interactive readings, short lectures, animations and case studies. This course on antidepressants is certified for 18.25 CME credits. An ideal resource for busy mental health professionals.
9
University of California, San Diego
Assisted by Meghan M. Grady
This book features one hundred and fifty new and updated questions derived from Dr Stahl’s Online Master Psychopharmacology Program which will help readers prepare for formal tests, including American Board of Psychiatry and Neurology examinations, and achieve CME and MoC credits towards ABPN reaccreditation. The self-assessment questions also offer detailed explanations of correct and incorrect answers. Contents: Introduction/preface; CME information; 1. Basic neuroscience; 2. Psychosis and schizophrenia and antipsychotics; 3. Unipolar depression and antidepressants; 4. Bipolar disorder and mood stabilizers; 5. Anxiety disorders and anxiolytics; 6. Chronic pain and its treatment; 7. Disorders of sleep and wakefulness and their treatment; 8. Attention deficit hyperactivity disorder (ADHD) and its treatment; 9. Dementia and cognitive function and its treatment; 10. Substance use and impulsive compulsive disorders and their treatment; CME: posttest and certificate; Index. 2016 186 x 123 mm 340pp 152 tables 978-1-316-50249-5 Paperback £39.99 / US$59.99 For all formats available, see
www.cambridge.org/9781316502495
Contents: Pre-course assessment; General principles of action; Antidepressant classes; Augmenting antidepressants; How to choose an antidepressant; Future treatments; Postcourse assessment. 2015 978-1-107-59483-8 Online Resource £65.00 / US$99.00 For all formats available, see
www.cambridge.org/9781107594838
eBooks available at www.cambridge.org/ebookstore
10
Stephen M. Stahl
Case Studies: Stahl’s Essential Psychopharmacology Volume 2 Stephen M. Stahl Neuroscience Education Institute
and Thomas L. Schwartz SUNY Upstate Medical University
This new selection of clinical stories, covers treatments that work, or fail, and mistakes made along the journey. Designed with a distinctive userfriendly presentation and making use of icons, questions/answers and tips, they address complex issues in an understandable way and with direct relevance to the everyday experience of clinicians. Contents: Introduction; List of icons; Abbreviations; 1. The case: achieving remission with medication management augmented with pet therapy; 2. The case: the luteal, jaw moving woman with paranoid paneling; 3. The case: the other lady with a moving jaw; 4. The case: the lady with MDD who bought an RV; 5. The case: the PCP who went the prescribing distance but came up short; 6. The case: intrusions, ammonia, and dyskinesias, oh my; 7. The case: the lady and the man who sat on couches; 8. The case: the lady who had her diagnosis altered; 9. The case: the man who picked things up; 10. The case: it worked this time, but with a hitch; 11. The case: the figment of a man who looked upon the lady; 12. The case: the man who couldn’t sell anymore; 13. The case: the woman who thought she was ill, then was ill; 14. The case: generically speaking, generics are OK; 15. The case: the woman who wouldn’t leave her car; 16. The case: the woman who liked late night TV; 17. The case: the patient who interacted with everything; 18. The case: the angry twins; 19. The case: anxiety, depression, or prebipolaring?; 20. The case: the patient who wasn’t lyming; 21. The case: hindsight is always 20/20 or ADHD; 22. The case: this one’s too hot, this one’s too cold… this one is just right; 23. The case: schizophrenia patient needs sleep; 24. The case: the man with greasy hands needs fine tuning; 25. The case: the combative business woman; 26. The case: the man with a little bit of everything; 27. The case: oops, he fell off the curve; 28. The case: 54-year-old with recurrent depression and ‘psychiatric’ Parkinsonism; 29. The case: 55-year-old with depression not responsive to serotonergic treatment; 30. The case: 23-year-old with first depression… that’s it!; Index of drug names; Index of case studies. 2016 228 x 139 mm 504pp 1 b/w illus. 24 colour illus. 6 tables 978-1-107-60733-0 Paperback £49.99 / US$79.99 Publication March 2016 For all formats available, see
www.cambridge.org/9781107607330
Violence in Psychiatry Edited by Katherine D. Warburton University of California, Davis
and Stephen M. Stahl University of California, San Diego
Focusing on violence from assessment, through underlying neurobiology, to treatment and other recommendations for practice, this book will be of interest to forensic psychiatrists, general adult psychiatrists, psychiatric residents, psychologists, psychiatric social workers and rehabilitation therapists. Contents: List of contributors; Part I. Statement of the Problem: 1. Deinstitutionalization and the rise of violence; 2. The new mission of forensic mental health systems: managing violence as a medical syndrome in an environment that balances treatment and safety; Part II. Assessment: 3. The evolution of violence risk assessment; 4. Assessment of aggression in inpatient settings; 5. Clinical assessment of psychotic and mood disorder symptoms for risk of future violence; 6. Inpatient aggression in community hospitals; 7. Prevalence of physical violence in a forensic psychiatric hospital system during 2011–13: patient assaults, staff assaults, and repeatedly violent patients; 8. The psychiatrist’s duty to protect; Part III. Neurobiology: 9. Deconstructing violence as a medical syndrome: mapping psychotic, impulsive, and predatory subtypes to malfunctioning brain circuits; 10. Aggression, DRD1 polymorphism, and lesion location in penetrating traumatic brain injury; 11. Is impulsive violence an addiction? The habit hypothesis; 12. The neurobiology of psychopathy: recent developments and new directions in research and treatment; 13. The neurobiology of violence; 14. Impulsivity and aggression in schizophrenia: a neural circuitry perspective with implications for treatment; 15. Serotonin and impulsive aggression; Part IV. Guidelines: 16. California State-Hospital Violence Assessment and Treatment (Cal-VAT) guidelines; Part V. Psychopharmacology: 17. Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study; 18. Clozapine: an effective treatment for seriously violent and psychotic men with antisocial personality disorder in a UK high-security hospital; 19. Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital; 20. The psychopharmacology of violence: making sensible decisions; 21. Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy; 22. A rational approach to employing high plasma levels of antipsychotics for violence associated with schizophrenia: case vignettes; 23. Illustrative
cases to support Cal-VAT guidelines; Part VI. Treatment Interventions: 24. A new standard of care for forensic mental health: prioritizing forensic intervention; 25. Forensic focused treatment planning: a new standard for forensic mental health systems; 26. Implementing an ecological approach to violence reduction at a forensic psychiatric hospital: approaches and lessons learned; 27. The appropriateness of treating psychopathic disorders; 28. Psychosocial approaches to violence and aggression: contextually anchored and trauma-informed interventions; 29. Co-morbid mental illness and criminalness: implications for housing and treatment; 30. Crime, violence and behavioral health: collaborative community strategies for risk mitigation; 31. New technologies in the management of risk and violence in forensic settings; 32. Risk reduction treatment of psychopathy and applications to mentally disordered offenders; Index. 2016 246 x 189 mm 360pp 10 b/w illus. 32 colour illus. 55 tables 978-1-107-09219-8 Hardback £54.99 / US$84.99 Publication May 2016 For all formats available, see
www.cambridge.org/9781107092198
Mental Health, Psychiatry and Clinical Psychology A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs
A Concise Guide to Understanding Suicide
Second edition D. G. Cunningham Owens
University of Miami
University of Edinburgh
This book provides a comprehensive, literature-based but clinically oriented overview of the pervasive neurological adverse effects that frequently affect those receiving antipsychotic (and pharmacologically related) drugs, giving valuable information to the wide range of healthcare professionals who prescribe and monitor these extensively utilised therapeutic agents. ‘This is an outstanding update of a very instructive book and should be mandatory reading for all trainees in psychiatry residency training programs – as well as their program directors … This book is like finding an oasis in a vast desert.’ Doody’s Reviews Contents: Preface; Part I. Setting the Scene: 1. The origins of psychopharma; 2. Some preliminaries; Part II. The Syndromes: 3. Acute dystonias; 4. Parkinsonism; 5. Akathisia; 6. Tardive dyskinesia; Part III. Particular Issues: 7. Tardive and chronic dystonia; 8. Special populations; Part IV. Assessment: 9. The clinical examination; 10. An overview of some standardised recording instruments; Part V. Matters Arising: 11. Involuntary movements and schizophrenia: a limitation to the concept of tardive dyskinesia?; 12. And finally … the salutary tale of ‘atypicality’; References; Index. 2014 246 x 189 mm 383pp 70 b/w illus. 72 tables 978-1-107-02286-7 Hardback £99.99 / US$155.00 For all formats available, see
www.cambridge.org/9781107022867
Epidemiology, Pathophysiology, and Prevention Edited by Stephen H. Koslow Pedro Ruiz University of Miami
and Charles B. Nemeroff University of Miami
Leading researchers summarize research on understanding, treating and preventing suicide and provide practical information for educating practising clinicians, health care workers and researchers and a pathway for undergraduate and graduate students interested in solutions to suicide. It will also appeal to the University community and lay public nationally and internationally.
11
32. Epigenetics; 33. The use of neuroimaging to investigate the pathophysiology of suicide; 34. Brain serotonin in suicides with psychological autopsy; 35. The noradrenergic system in depression and suicide; 36. Brain CRF and the HPA axis in suicide; 37. Receptor signaling in suicide; Part VI. Suicide Prevention: 38. Strategies to improve suicide prevention; 39. Safety planning to prevent suicidal behavior; 40. Contracting for safety; 41. Suicide and the media; Index. 2014 246 x 189 mm 406pp 28 b/w illus. 8 colour illus. 20 tables 978-1-107-03323-8 Hardback £79.99 / US$125.00 For all formats available, see
www.cambridge.org/9781107033238
Contents: Introduction: looking to the future – how can research prevent suicide?; Part I. Understanding Suicide: 1. Brief history of suicide in Western cultures; 2. Global epidemiology of suicide; 3. Identification and screening of suicide risk; 4. Rethinking suicide risk assessment and risk formulation; 5. High risk cognitive states; 6. Suicide clusters and suicide contagion; 7. Ethnicity: how much of our understanding of suicide is applicable across ethnic cultures?; 8. Suiciderelated bereavement and grief; 9. Statistics; Part II. Suicidal Comorbidities: 10. Current and chronic signs and symptoms; 11. Anxiety, depression and suicide: epidemiology, pathophysiology and prevention; 12. Suicide in schizophrenia; 13. Personality disorders and suicide; 14. Suicide and substance use disorders; 15. Eating disorders and suicide; 16. Suicidality and epilepsy: a complex relationship; Part III. Special Populations: 17. Suicidal ideation and behavior during pregnancy and the postpartum period; 18. Childhood and adolescence; 19. Indigenous/native populations; 20. Bullying and suicidality in youth; 21. College students; 22. Suicide in older adults; 23. Armed forces; 24. Medical illness; 25. Suicide in the criminal justice system; Part IV. Treatment: 26. Reduction of suicidal behavior in bipolar disorder patients during long-term treatment with lithium; 27. Clozapine; 28. Antidepressants; 29. Suicide and emergency room treatment; 30. Psychosocial approaches to reduce suicidal behavior; Part V. Research: Mediators and Moderators: 31. Genome-wide association studies of suicidal behaviors;
For regular email alerts visit www.cambridge.org/alerts
12
Mental Health, Psychiatry and Clinical Psychology
Attention-Deficit Hyperactivity Disorder in Adults and Children Edited by Lenard A. Adler New York University School of Medicine
Thomas J. Spencer Harvard Medical School
and Timothy E. Wilens Massachusetts General Hospital
A comprehensive text, written by leading experts, detailing the significant advances in the treatment of ADHD in both children and adults. The wide ranging coverage includes the history, diagnosis, comorbidity, new psychopharmacologic medications and cognitive and behavioral therapy techniques for anyone involved in the assessment and management of ADHD. Contents: Preface; 1. Introduction; 2. History of attention-deficit/hyperactivity disorder (ADHD); 3. Diagnosing ADHD in children and Adults; 4. The epidemiology and societal burden of ADHD; 5. Functional impairment in ADHD; 6. Beyond DSM-IV diagnostic criteria: what changed and what should have changed in DSM-5; 7. Conceptual issues in understanding comorbidity in ADHD; 8. Bipolar disorder and ADHD: comorbidity throughout the lifecycle; 9. Assessment and treatment of depressive disorders in adults with ADHD; 10. Comorbidity of ADHD and
anxiety disorders: diagnosis and treatment across the lifespan; 11. Attention-deficit/ hyperactivity disorder and the substance use disorders in ADHD; 12. ADHD and learning disorders; 13. Oppositional defiant disorder and conduct disorder; 14. Mimics of ADHD: medical and neurological conditions; 15. Catecholamine influences on prefrontal cortex circuits and function; 16. Molecular genetics of ADHD; 17. Neuroimaging of ADHD; 18. Neuropsychological testing; 19. ADHD diagnostic and symptom assessment scales for adults; 20. Assessment of ADHD in children and adolescents; 21. Stimulant medication in children and adolescents; 22. Non-stimulant treatment of ADHD; 23. Pharmacotherapy of ADHD in adults; 24. Psychosocial treatment of ADHD in adults; 25. Complementary and alternative treatments for pediatric and adult ADHD; 26. Preschool ADHD treatment; 27. ADHD and smoking; 28. ADHD and Tourette’s disorder; 29. Sustainable change: treatment adherence in ADHD; 30. College students with ADHD; Index. 2015 246 x 189 mm 410pp 14 b/w illus. 28 tables 978-0-521-11398-4 Hardback £75.00 / US$120.00 For all formats available, see
www.cambridge.org/9780521113984
Functional Remediation for Bipolar Disorder Eduard Vieta Universitat de Barcelona
Carla Torrent Hospital Clinic of Barcelona
and Anabel Martínez-Arán Hospital Clinic of Barcelona
Managing cognitive deficits in bipolar disorder presents a significant challenge. This manual describes the implementation of interventions aimed at improving the functional and social recovery of patients. A valuable resource for psychologists, psychiatrists, and other healthcare professionals caring for patients with bipolar disorder. Contents: Preface; Acknowledgements; 1. Cognition and functioning in bipolar disorder; 2. Cognitive remediation in psychiatric disorders; 3. Functional remediation in bipolar patients; 4. Functional remediation programme: sessions and content; 5. Efficacy of the functional remediation programme; Appendices; References; Index. 2014 297 x 210 mm 142pp 42 b/w illus. 3 tables 978-1-107-66332-9 Paperback £35.00 / US$55.00 For all formats available, see
www.cambridge.org/9781107663329
Be the first to hear about the academic products in your area of interest and receive 20% off your first online order
Cambridge Alerts Sign up today at www.cambridge.org/alerts
33286
T&Cs: www.cambridge.org/alertstcs